Document Detail


Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease.
MedLine Citation:
PMID:  22377247     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background/Aim: Oxidative stress (OS) is involved in left ventricular hypertrophy (LVH). Short-term treatment with erythropoietin (EPO) in chronic kidney disease (CKD) complicated by anemia and LVH is associated with a reduction in left ventricular mass (LVM). We proposed to assess whether the pro-oxidant status of CKD influences these outcomes. Methods: Predialysis patients (n = 76) with CKD and hemoglobin (Hb) levels < 11 g/dl received EPO for 6 months. The effects of this anemia correction on LVH regression were evaluated using echocardiography. Patients with LVM decrease > 10% were considered "responders" (n = 25) to treatment and those with LVM change < 10% were considered "non-responders" (n = 24). Measurement of OS included plasma and erythrocyte oxidized (GSSG) and reduced (GSH) glutathione, GSH redox ratio (GSSG/GSH), erythrocyte glutathione peroxidase (GPx) and oxidized LDL (Ox- LDL). Results: 49 patients completed the study. With EPO therapy, mean Hb levels increased from 9.9 ± 0.6 to 12.8 ± 1.5 g/ dl (p < 0.0001) and LVM index decreased from 69.2 ± 17.7 to 64.1 ± 19.6 g/m2.7 (p = 0.01). At 6 months, "non-responders" had higher systolic blood pressure, pulse pressure, GSSG and GSH redox ratio and lower GSH than "responders". In multivariate analysis, and following adjustment for confounding variables, systolic blood pressure and GSH redox ratio independently predicted LVH regression. Conclusion: Blood pressure and plasma GSH redox ratio (a marker of OS) are important predictors of LVH regression in anemic predialysis patients treated with EPO.
Authors:
Alberto Martinez-Vea; Luis Marcas; Alfredo Bardají; Marta Romeu; Cristina Gutierrez; Carmen García; Teresa Compte; Rosa Nogues; Carmen Peralta; Montserrat Giralt
Related Documents :
15811867 - Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and l...
17287367 - Ros scavenging before 27 degrees c ischemia protects hearts and reduces mitochondrial r...
10509357 - A limited interval of delayed modest hypothermia for ischemic brain resuscitation is no...
9205547 - Short-term inhibition of the na-h exchanger limits acidosis and reduces ischemic injury...
6498577 - Effect of halogenated anaesthetics on heart rate changes during reversal of neuromuscul...
11371487 - Ocular pulse amplitude is reduced in patients with advanced retinitis pigmentosa.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical nephrology     Volume:  77     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  171-81     Citation Subset:  IM    
Affiliation:
Nephrology Service, Cardiology Service, Research Unit, of the Hospital Universitari de Tarragona Joan XXIII, IISPV, Pharmacology Unit, Department of Basic Medical Sciences, Universitat Rovira i Virgili, Tarragona, and Nephrology Assistance Unit, Hospital de Jesús, Tortosa, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of hospital location on short-term fate of premature infants born at 34 weeks of gestation...
Next Document:  Is the sodium level per se related to mortality in hospitalized patients with severe hyponatremia?